1. Home
  2. DOGZ vs MOLN Comparison

DOGZ vs MOLN Comparison

Compare DOGZ & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DOGZ

Dogness (International) Corporation

HOLD

Current Price

$0.99

Market Cap

153.5M

ML Signal

HOLD

Logo Molecular Partners AG

MOLN

Molecular Partners AG

HOLD

Current Price

$3.88

Market Cap

151.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
DOGZ
MOLN
Founded
2003
2004
Country
China
Switzerland
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
153.5M
151.9M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
DOGZ
MOLN
Price
$0.99
$3.88
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$8.38
AVG Volume (30 Days)
38.6K
3.5K
Earning Date
04-01-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$374.07
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.96
$3.41
52 Week High
$30.00
$5.36

Technical Indicators

Market Signals
Indicator
DOGZ
MOLN
Relative Strength Index (RSI) 37.44 44.37
Support Level N/A $3.58
Resistance Level $1.41 $3.96
Average True Range (ATR) 0.09 0.15
MACD 0.01 0.01
Stochastic Oscillator 23.08 32.07

Price Performance

Historical Comparison
DOGZ
MOLN

About DOGZ Dogness (International) Corporation

Dogness (International) Corp designs, manufactures pet products, including leashes and smart products, and lanyards. The company designs, processes, and manufactures fashionable and high-quality leashes, collars, and harnesses to complement cats' and dogs' appearances, as well as intelligent pet products. The company also provides dyeing services to external customers, as well as pet grooming services. The dyeing service is to utilize the existing production capacity and the pet grooming service is immaterial. Geographically, it generates maximum revenue from Mainland China and also has a presence in the United States, Europe, Australia, Canada, Central, and South America, Japan, and other Asian countries and regions.

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company is currently focusing on oncology through their robust pipeline of clinical and preclinical programs, with particular attention to MP0712, the key Radio-DARPin candidate targeting DLL3 now in a Phase 1/2a trial in the United States.

Share on Social Networks: